ArticleCancers2020

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis.

Antonio Facciorusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.